For the past 30 years, UCSF has been a leader in AIDS basic and clinical research, patient care, policy development and community and global outreach, efforts that were among the first in the nation in response to the epidemic.
June 06, 2011
May 13, 2011
The campus community is invited to hear about the past, present and future of UCSF's role in combatting HIV/AIDS during a forum on May 17 to mark 30 years of AIDS and the official kick off the University's participation in the 25th annual AIDS Walk San Francisco.
February 24, 2011
Among those cheering the recent opening of the new stem cell science building at UCSF were two patient advocates who have a personal connection to advancing the field of regenerative medicine.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
November 05, 2010
UCSF’s recent Bay Area Global Health Summit ignited robust discussion in hopes of stimulating ideas that lead to tangible progress toward advancing health worldwide™.
October 13, 2010
John Greenspan, a distinguished professor of oral pathology and pathology in the schools of dentistry and medicine, respectively, has been appointed associate dean for Global Oral Health in the UCSF School of Dentistry.
August 17, 2010
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
July 02, 2010
HIV-infected patients who lost subcutaneous fat as a result of taking first-generation antiretroviral drugs still had strikingly less body fat than non-infected controls five years after switching to newer medications, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
May 19, 2010
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.
May 12, 2010
Understanding the processes underlying the diminishing life span of HIV patients, even though they are responding well to anti-retroviral therapy, will be the focus of a daylong symposium on May 18.